Open Access Open Access  Restricted Access Subscription Access

A Review of Platelet Rich Plasma Therapy Used Obstetrics and Gynaecology

Saleena Resheed, Shalini V Samson

Abstract


Platelet-Rich Plasma (PRP) Therapy in Obstetrics and Gynaecology: A Promising Treatment Approach. PRP therapy has emerged as a novel treatment approach in various medical fields, including Obstetrics and Gynaecology. PRP therapy has shown promising results in improving ovarian function, endometrial thickness, and menstrual health in women with various reproductive disorders. The therapy has also been effective in enhancing fertility outcomes and reducing symptoms of Asherman's syndrome.

 


Full Text:

PDF

References


Platelet-rich plasma therapy for ovarian rejuvenation. (2018). Journal of Assisted Reproduction and Genetics.

Autologous platelet-rich plasma therapy for Asherman's syndrome. (2019). Journal of Minimally Invasive Gynaecology.

Platelet-rich plasma therapy for endometrial thickness and receptivity. (2020). Fertility and Sterility.

PRP therapy for polycystic ovary syndrome: A systematic review. (2020). Reproductive Biomedicine Online.

Platelet-rich plasma therapy in reproductive medicine. (2020). Springer.

Regenerative medicine in obstetrics and gynaecology. (2019). CRC Press.

PRP therapy for ovarian rejuvenation: A pilot study. (2019). European Society for Human Reproduction and Embryology.

Autologous platelet-rich plasma therapy for Asherman's syndrome: A case series. (2020). American Association of Gynaecologic Laparoscopists.

American Society for Reproductive Medicine (ASRM). (2020). Platelet-rich plasma therapy.

Society for Assisted Reproductive Technology (SART). (2020). PRP therapy for ovarian rejuvenation.

International Society for Stem Cell Research (ISSCR). (2020). Regenerative medicine in obstetrics and gynaecology.

A randomized controlled trial of PRP therapy for ovarian rejuvenation. (2020). ClinicalTrials.gov.

A prospective study of autologous platelet-rich plasma therapy for Asherman's syndrome. (2020). ResearchGate.


Refbacks

  • There are currently no refbacks.